This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Olin (OLN) Misses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Olin (OLN) faced challenges from weakness in caustic soda pricing in the first quarter.
Olin (OLN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Olin (OLN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Pick Olin Corporation (OLN) Stock?
by Zacks Equity Research
Is Olin Corporation (OLN) a great pick from the value investor's perspective right now? Read on to know more.
Olin (OLN) Looks Good: Stock Adds 5.7% in Session
by Zacks Equity Research
Olin (OLN) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Olin (OLN) Down 7.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Olin (OLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Olin (OLN) Jumps: Stock Rises 8.7%
by Zacks Equity Research
Olin (OLN) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Olin (OLN) Misses Earnings and Revenue Estimates in Q4
by Anindya Barman
Olin (OLN) expects adjusted EBITDA for 2019 to be comparable to 2018 levels.
Olin (OLN) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of -5.88% and -4.14%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olin (OLN) Up 7.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Olin (OLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Olin (OLN) Surpasses Earnings & Revenue Estimates in Q3
by Zacks Equity Research
Olin (OLN) expects adjusted EBITDA for 2018 to be around $1.26 billion.
Olin (OLN) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 1.35% and 1.56%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Olin (OLN) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the First Trust Materials AlphaDEX Fund (FXZ)?
by Zacks Equity Research
Sector ETF report for FXZ
Implied Volatility Surging for Olin (OLN) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Olin (OLN) stock based on the movements in the options market lately.
Why Is Olin (OLN) Up 6.8% Since Last Earnings Report?
by Zacks Equity Research
Olin (OLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Olin Corp (OLN) Q2 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
Olin (OLN) raises adjusted EBITDA forecast for 2018.
Chemical Stock Earnings to Watch on Jul 31: ECL, HUN & More
by Anindya Barman
Chemical stocks reporting earnings on Jul 31 are unlikely to impress.
Chemical Stock Earnings to Watch on Feb 6: AXTA, CBT & More
by Zacks Equity Research
Most of the chemical stocks reporting earnings on Feb 6 are unlikely to impress.
5 Best Value Picks Based on PEG Ratio
by Zacks Equity Research
For investors looking to escape value traps, it is also vital to determine where the stock is headed in the next 12 to 24 months.
Stock Market News For Oct 3, 2017
by Zacks Equity Research
Benchmarks closed near record highs on Monday following a rally in the financial and healthcare stocks.
Olin Corporation (OLN) Soars: Stock Adds 6.6% in Session
by Zacks Equity Research
Olin Corporation (OLN) saw its shares rise nearly 7% on the day.
Praxair (PX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Praxair (PX) is likely to benefit from improving market conditions, benefits from contract wins and new product launches in second-quarter 2017. Forex issues and stiff competition remain concerns.
Olin Corporation (OLN): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Olin Corporation (OLN) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
Implied Volatility Surging for Olin Corporation (OLN) Stock Options
by Zacks Equity Research
Investors in Olin Corporation (OLN) need to pay close attention to the stock based on moves in the options market lately.